黑料网

Skip to main content

Genetically Engineered Mouse Models

Breast

听

  • C3(1)Tag听鈥撎�This model is similar to the human Triple negative breast cancer of basal-like sub-type as shown by gene expression analysis (Pfefferele et al., Genome Biology 2013听鈥� PMID 24220145). The C3(1)/Tag model is a non-hormone influenced model utilizing the 5鈥� flanking region of the C3(1) component of the rat prostate steroid binding protein (PSBP) to target the expression of Simian Virus 40 (SV40) large T-antigen (Tag) to the epithelium of both the mammary and prostate glands. SV40 large Tag has been shown to inactivate both p53 and RB (Green et al., Oncogene 2000听鈥� PMID 10713685). 听Importantly, inactivates of p53 and RB are known to be contribute to these important genetic lessons of human basal-like cancer.

听

  • MMTV-Neu 鈥撎�The Neu model represents HER2 positive breast cancer tumors. It is an autochthonous breast cancer model that is driven by over-expression a non-activated Rat听neu听transgene by mouse mammary tumor virus (MMTV) promoter.听 (Guy et al., PNAS 1992 鈥� PMID:听 PMC50384).

 

  • MMTV-PyVT 鈥撎�A triple negative breast cancer model with a fast rate of metastasis.

Melanoma听

  • TRIA 鈥� 听This model examines Tyr-Hras in mice with specific deficiencies of p16 Ink4A 鈥� and p19 Arf 鈥� (Loss of p16Ink4a With Retention of p19Arf Predisposes Mice to Tumorigenesis Sharpless NE, Bardeesy N, Lee KH, Carrasco D, Castrillon DH, Aguirre AJ, Wu EA, Horner JW and DePinho RA . (2001).听Nature,听413, 86鈥�91.) All male animals carry the Hras mutation and both Ink and Arf have been knocked out. Latency with the TRIA is 14-20 weeks with approximately 80% penetrance and the tumors generally present on the pinnia and tail.

 

 

  • Braf v600E; Pten; Tyr-Cre 鈥撎�This inducible Cre recombinant model deletes Pten to drive expression of Braf in site specific tumorigenesis. Using topically applied tamoxifen at the base of the tail, a pigmented tumor will present in 4-8 weeks. The ptenbraf model is susceptible to spontaneous secondary tumors due to the potential 鈥渓eakiness鈥� of the tyrosinase Cre. Homozygous Braf has a higher incidence of very aggressive tumor growth, therefore we maintain the line with heterozygous Braf.